DUBLIN, June 10, 2016 /PRNewswire/ --

Research and Markets has announced the addition of the "Global Central Nervous System (CNS) Biomarkers Market Insights, Opportunity, Analysis, Market Shares And Forecast 2016 - 2022" report to their offering.

The global CNS biomarker market is expected to reach up to $6.2 billion by 2022 growing at 10.4% CAGR during 2016-2022.

The demand for CNS biomarker has increased with the development of in proteomics, genomics and imaging system, which is a major drivers of the Global Central Nervous System Biomarkers Market. The global CNS biomarker market is witnessing a moderate to high growth in the recent years and is expected to continue so on in the near future.

The major factors identified that are driving the CNS biomarker market are support from private players and government for increased research and development, development of genomics and imaging system, rapidly increasing aging population and increased public private partnerships.

Recently, FDA has approved use CNS biomarkers which has led to its significant growth in the North American region. The world is experiencing a significant growth in aging population. As per Administration for Community Living, population aged 65 and above is estimated to reach more than 80 million by 2050, which is twice of that estimated in 2012.

Key Topics Covered:

1. Introduction

2. Market Overview

3. Market Determinants

4. Market Segmentation

5. Geographical Analysis

6. Company Profiling: - (Over, Scot Analysis, Strategic Review)

- Abastar Mdx Inc 

- Abiant Inc

- Acumen Pharmaceuticals Inc

- Adlyfe Inc

- Alseres Pharmaceuticals Inc

- Apitope International

- Aposense

- Applied Neurosolutions Inc

- Avacta Group Plc

- Avid Radiopharmaceuticals Inc

- Banyan Biomarkers

- Diagenic Asa

- Ekfdiagnostics Holdings Inc

- Enzo Biochem Inc

- Exonhit Therapeutics

- Genenews Ltd

- Glycominds Ltd

- Great Lakes Neurotechnologies

- Innogenetics Biologicals

- Innovative Neurotechnologies Inc

- Merc & Co. In

- Metabolon Inc

- Myriad Rbm Inc

- Oligomerix Inc

- Opko Health Inc

- Osta Biotechnologies Inc

- Proteome Sciences Products

- Psynova Neurotech Ltd

- Ridge Diagnostics

- Sabiosciences

- Satori Pharmaceutical Inc

- Thermo Fisher Scientific

For more information visit http://www.researchandmarkets.com/research/fpj7lb/global_central

Media Contact:

Research and Markets

Laura Wood, Senior Manager

press@researchandmarkets.com

For E.S.T Office Hours Call +1-917-300-0470

For U.S./CAN Toll Free Call +1-800-526-8630

For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907

Fax (outside U.S.): +353-1-481-1716

Related Links

http://www.researchandmarkets.com

SOURCE Research and Markets